Literature DB >> 19152451

Clinical expression of insulin resistance in hepatitis C and B virus-related chronic hepatitis: differences and similarities.

Marcello Persico1, Mario Masarone, Vincenzo La Mura, Eliana Persico, Francesco Moschella, Monica Svelto, Savino Bruno, Roberto Torella.   

Abstract

AIM: To investigate the prevalence of the clinical parameters of insulin resistance and diabetes in patients affected by chronic hepatitis C (CHC) or chronic hepatitis B (CHB).
METHODS: We retrospectively evaluated 852 consecutive patients (726 CHC and 126 CHB) who had undergone liver biopsy. We recorded age, sex, ALT, type 2 diabetes and/or metabolic syndrome (MS), body mass index (BMI), and apparent disease duration (ADD).
RESULTS: Age, ADD, BMI, prevalence of MS and diabetes in patients with mild/moderate liver fibrosis were significantly higher in CHC. However, the degree of steatosis and liver fibrosis evaluated in liver biopsies did not differ between CHC and CHB patients. At multivariate analysis, age, sex, BMI, ALT and diabetes were independent risk factors for liver fibrosis in CHC, whereas only age was related to liver fibrosis in CHB. We also evaluated the association between significant steatosis (>30%) and age, sex, BMI, diabetes, MS and liver fibrosis. Diabetes, BMI and liver fibrosis were associated with steatosis >30% in CHC, whereas only age and BMI were related to steatosis in CHB.
CONCLUSION: These data may indicate that hepatitis C virus infection is a risk factor for insulin resistance.

Entities:  

Mesh:

Year:  2009        PMID: 19152451      PMCID: PMC2653368          DOI: 10.3748/wjg.15.462

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  40 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease.

Authors:  N N Zein; A S Abdulkarim; R H Wiesner; K S Egan; D H Persing
Journal:  J Hepatol       Date:  2000-02       Impact factor: 25.083

3.  Metabolic factors involved in the therapeutic response of patients with hepatitis C virus-related chronic hepatitis.

Authors:  Giovanni Tarantino; Paolo Conca; Paolo Sorrentino; Manuela Ariello
Journal:  J Gastroenterol Hepatol       Date:  2006-08       Impact factor: 4.029

Review 4.  Interaction of non-alcoholic fatty liver disease with other liver diseases.

Authors:  Andrew D Clouston; Elizabeth E Powell
Journal:  Best Pract Res Clin Gastroenterol       Date:  2002-10       Impact factor: 3.043

5.  Increased frequency of HCV and HBV infection in type 2 diabetic patients.

Authors:  L Sangiorgio; T Attardo; R Gangemi; C Rubino; M Barone; M Lunetta
Journal:  Diabetes Res Clin Pract       Date:  2000-05       Impact factor: 5.602

6.  Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.

Authors:  L E Adinolfi; M Gambardella; A Andreana; M F Tripodi ; R Utili; G Ruggiero
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

7.  Chronic hepatitis C and superimposed nonalcoholic fatty liver disease.

Authors:  J P Ong; Z M Younossi; C Speer; A Olano; T Gramlich; N Boparai
Journal:  Liver       Date:  2001-08

8.  Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States.

Authors:  S H Mehta; F L Brancati; M S Sulkowski; S A Strathdee; M Szklo; D L Thomas
Journal:  Ann Intern Med       Date:  2000-10-17       Impact factor: 25.391

9.  Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.

Authors:  L Castéra; C Hézode; F Roudot-Thoraval; A Bastie; E-S Zafrani; J-M Pawlotsky; D Dhumeaux
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

10.  Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol.

Authors:  Alexander Monto; Judy Alonzo; Jessica J Watson; Carl Grunfeld; Teresa L Wright
Journal:  Hepatology       Date:  2002-09       Impact factor: 17.425

View more
  10 in total

Review 1.  Epidemiology of hepatitis C virus in Iran.

Authors:  Reza Taherkhani; Fatemeh Farshadpour
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

2.  Insulin resistance in non-diabetic patients of chronic Hepatitis C.

Authors:  Zareen Kiran; Bader Faiyaz Zuberi; Daniah Anis; Rashid Qadeer; Khalid Hassan; Salahuddin Afsar
Journal:  Pak J Med Sci       Date:  2013-01       Impact factor: 1.088

Review 3.  Steatosis as a co-factor in chronic liver diseases.

Authors:  Marcello Persico; Achille Iolascon
Journal:  World J Gastroenterol       Date:  2010-03-14       Impact factor: 5.742

4.  Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis C.

Authors:  Hirokazu Takahashi; Toshihiko Mizuta; Yuichiro Eguchi; Yasunori Kawaguchi; Takuya Kuwashiro; Satoshi Oeda; Hiroshi Isoda; Noriko Oza; Shinji Iwane; Kenichi Izumi; Keizou Anzai; Iwata Ozaki; Kazuma Fujimoto
Journal:  J Gastroenterol       Date:  2011-02-18       Impact factor: 7.527

5.  Association between diabetes mellitus and cirrhosis mortality: the Singapore Chinese Health Study.

Authors:  George Boon-Bee Goh; An Pan; Wan-Cheng Chow; Jian-Min Yuan; Woon-Puay Koh
Journal:  Liver Int       Date:  2016-09-16       Impact factor: 5.828

6.  Insulin resistance, steatosis, and fibrosis in Egyptian patients with chronic Hepatitis C virus infection.

Authors:  Ahlam M Ahmed; Magda S Hassan; Alaa Abd-Elsayed; Huwayda Hassan; Ahmad F Hasanain; Ahmed Helmy
Journal:  Saudi J Gastroenterol       Date:  2011 Jul-Aug       Impact factor: 2.485

7.  Effect of coexisting diabetes mellitus and chronic kidney disease on mortality of cirrhotic patients with esophageal variceal bleeding.

Authors:  Chia-Chi Lung; Zhi-Hong Jian; Jing-Yang Huang; Oswald Ndi Nfor
Journal:  BMC Gastroenterol       Date:  2016-02-29       Impact factor: 3.067

8.  Application of network construction to estimate functional changes to insulin receptor substrates 1 and 2 in Huh7 cells following infection with the hepatitis C virus.

Authors:  Jingkun Liu; Linbang Wang; Wenjun Wang; Yaping Li; Xiaoli Jia; Song Zhai; Juan Shi; Shuangsuo Dang
Journal:  Mol Med Rep       Date:  2016-07-18       Impact factor: 2.952

Review 9.  Intrahepatic vascular changes in non-alcoholic fatty liver disease: Potential role of insulin-resistance and endothelial dysfunction.

Authors:  Marcos Pasarín; Juan G Abraldes; Eleonora Liguori; Beverley Kok; Vincenzo La Mura
Journal:  World J Gastroenterol       Date:  2017-10-07       Impact factor: 5.742

Review 10.  Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review.

Authors:  Anne-Claire Desbois; Patrice Cacoub
Journal:  World J Gastroenterol       Date:  2017-03-07       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.